Year: 2025
Type: article
Study design: Case Report
Abstract: Cannabinoid hyperemesis syndrome (CHS) is a condition in which users of marijuana experience symptoms of nausea and vomiting. Due to the nature of the condition, patients may ultimately be admitted to the hospital for complications such as weakness and fluid loss. The usual treatment options for nausea and vomiting include fluids and a combination of metoclopramide, ondansetron, promethazine, or prochlorperazine. We present a case where fosaprepitant was utilized for intractable nausea and vomiting when other treatment modalities failed for CHS.
Source: Cureus
DOI: 10.7759/cureus.90477
Authors: Markus D Moore, Saeed K Alzghari, Andrew N Soliman
Institution: Texas Health Harris Methodist Hospital Fort Worth
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4413310694